// App-Quantinova.ai

P6.340 : Treatment with interferon reduces the appearance of lesions in clinically relevant white matter (WM) tracts in patients with clinically isolated syndrome (CIS) (P6.340)

Researchers

Presenter

  • Marco Battaglini

Principal Investigators

  • Hugo Vrenken

  • R Tappa Brocci

  • G Gentile

  • L Luchetti

  • A Versteeg

  • Mark Freedman

  • Bernard Uitdehaag

  • Ludwig Kappos

  • Giancarlo Comi

  • Frederik Barkhof

  • Nicola De Stefano

Medical Centers

  • University Hospital Basel, Basel, Switzerland

  • University Hospital of Siena, Siena, Italy

  • VU University Medical Center, Amsterdam, Netherlands

  • Department of Ophthalmology, Scientific Institute San Raffaele, University Vita-Salute, Milan, Italy

  • University of Ottawa, and Ottawa Hospital Research Institute, Ottawa, ON, Canada

  • 3Institutes of Neurology and Healthcare Engineering, University College London, London, UK Amsterdam Netherlands

  • Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, Netherlands

Locations

  • Switzerland

  • Italy

  • Netherlands

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Interferon

Outcome

  • N/A

Study Design

  • Placebo Control

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved